Literature DB >> 8552994

Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-gamma.

W Z Wang1, S Fredrikson, J B Sun, H Link.   

Abstract

The T-cell response to the aetiologic pathogen Borrelia (B.) burgdorferi in patients with Lyme neuroborreliosis (LN) and in control patients with other neurological diseases was examined by enumerating B. burgdorferi-reactive T cells secreting interferon-gamma (IFN-gamma) with an ELIspot assay. LN patients had elevated numbers of B. burgdorferi-reactive IFN-gamma secreting cells in blood and approximately 20-fold enriched in the cerebrospinal fluid (CSF). A positive correlation existed in CSF between B. burgdorferi-reactive IFN-gamma secreting cells and B cells secreting anti-B. burgdorferi IgG antibodies. The up-regulation of antigen-specific IFN-gamma secreting cells persisted in peripheral blood up to at least 9 months and in the CSF for at least 4 months after termination of treatment with antibiotics, when the patients were mostly free from clinical signs and symptoms due to LN. How IFN-gamma interplays with other cytokines and influences the pathogenesis of LN remains to be studied.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552994     DOI: 10.1111/j.1365-3083.1995.tb03713.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

Authors:  C Ekerfelt; M Andersson; A Olausson; S Bergström; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

2.  Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-specific interferon-gamma (IFN-gamma)-secreting cells in blood as patients with clinical Borrelia infection.

Authors:  C Ekerfelt; P Forsberg; M Svenvik; M Roberg; S Bergström; J Ernerudh
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 3.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

4.  Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis.

Authors:  Mona Widhe; Mattias Grusell; Christina Ekerfelt; Magnus Vrethem; Pia Forsberg; Jan Ernerudh
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis.

Authors:  Geeta Ramesh; Juan T Borda; Jason Dufour; Deepak Kaushal; Ramesh Ramamoorthy; Andrew A Lackner; Mario T Philipp
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

6.  Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans.

Authors:  Johanna Sjöwall; Linda Fryland; Marika Nordberg; Florence Sjögren; Ulf Garpmo; Christian Jansson; Sten-Anders Carlsson; Sven Bergström; Jan Ernerudh; Dag Nyman; Pia Forsberg; Christina Ekerfelt
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

7.  Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?

Authors:  Marika Nordberg; Pia Forsberg; Dag Nyman; Barbro H Skogman; Clara Nyberg; Jan Ernerudh; Ingvar Eliasson; Christina Ekerfelt
Journal:  Cells       Date:  2012-06-08       Impact factor: 6.600

8.  An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.

Authors:  T van Gorkom; S U C Sankatsing; W Voet; D M Ismail; R H Muilwijk; M Salomons; B J M Vlaminckx; A W J Bossink; D W Notermans; J J M Bouwman; K Kremer; S F T Thijsen
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

9.  Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.

Authors:  Geeta Ramesh; Juan T Borda; Amy Gill; Erin P Ribka; Lisa A Morici; Peter Mottram; Dale S Martin; Mary B Jacobs; Peter J Didier; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 9.587

10.  ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis.

Authors:  N Ettischer-Schmid; R Preyer
Journal:  Clin Exp Immunol       Date:  2020-04-14       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.